46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04530305 (ClinicalTrials.gov)	January 7, 2021	24/8/2020	Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor	Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor	Rheumatoid Arthritis	Drug: Tofacitinib 5 MG [Xeljanz]	University Hospital, Montpellier	NULL	Recruiting	18 Years	N/A	All	60		France
2	NCT03980483 (ClinicalTrials.gov)	May 16, 2019	15/5/2019	Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to ...	A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK31 ...	Arthritis, Rheumatoid;Glycogen Storage Disease Type II	Biological: GSK3196165 (Otilimab);Drug: Tofacitinib 5 mg;Drug: Placebo to GSK3196165;Drug: Placebo to ...	GlaxoSmithKline	Iqvia Pty Ltd	Active, not recruiting	18 Years	N/A	All	1537	Phase 3	United States;Argentina;Canada;China;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Po ...
3	NCT03755466 (ClinicalTrials.gov)	November 21, 2018	21/11/2018	Examination of Efficacy and Safety of Baricitinib in RA Patients	Efficacy and Safety of Baricitinib in Rheumatoid Arthritis Patients Compared With Those Treated by B ...	Rheumatoid Arthritis	Drug: Baricitinib , olumiant®;Drug: Biologics;Drug: Tofacitinib 5 MG [Xeljanz]	Shinshu University	NULL	Recruiting	20 Years	N/A	All	90	Phase 2	Japan

First Previous1Next Last